GAC - Your are correct that would be a reverse takeover. It was talked about at an AGM within the last 3? years, as well as on this board briefly. As far as I can remember the idea never got legs and was dropped.

If there was a dead or very badly beaten up Biotech that was cleaned up and still listed there is merit to the idea. If the shell is in any other industry than Biotech it could end up being a very bad idea. Sometimes Reverse takeovers can present many more hurdles than going through in IPO listing.

I'm just going to put my rose coloured glasses on and expect a buyout offer shortly after spectacular Top Line Results are announced. That way we don't have to concern ourselves with a listing on the NAZ at all. We can watch the unicorn ride by and live happily ever after.

tick - tock let's go!

tada